Skip Ribbon Commands
Skip to main content
A- A A+

News & Stories

3
Feb
2020

Singapore Hosts International Commission on Healthy Longevity

National University Health System

The human race is at the cusp of a demographic transition, experiencing rapidly ageing populations coupled with declining birth rates all around the world. To successfully mitigate this and build a critical support framework, the United States of America's National Academy of Medicine (NAM) is spearheading an international, independent and multidisciplinary initiative to develop a Global Roadmap for Healthy Longevity that will identify – through evidence-based recommendations – the necessary priorities and directions for improving health, productivity and quality of life worldwide.

Singapore is privileged to be chosen as the site for the two-day Health Care Systems & Public Health: A Workshop for the Global Roadmap for Healthy Longevity Initiative, organised by NAM from 3 to 4 February 2020, in partnership with the MOH Office for Healthcare Transformation (MOHT), the National University Health System (NUHS), the National University of Singapore (NUS) and the National Research Foundation Singapore (NRF).

NUHS Media Release
21
Oct
2019

NUHS Chief Executive elected to U.S. National Academy of Medicine

National University Health System

NUHS Media Release
29
Aug
2019
14
May
2019
6
May
2019
24
Apr
2019
3
Apr
2019

A Ray of Hope for Organ Transplant Patients

National University Hospital

NUH Media ReleaseNUHS Media Release
6
Jul
2018

A Glimpse into Hospitals of the Future

Others

​Healthcare professionals, data scientists and medical innovators are coming together to showcase innovative healthcare technologies and Artificial Intelligence (AI) tools at a first-of-itskind public sector symposium and exhibition in Singapore. The National University Health System (NUHS) will also launch its own healthcare AI system: DISCOVERY AI – a learning data-driven platform that can assist the healthcare team by refining data and information to enhance clinical diagnoses, flag higher-risk patients, and automate hospital processes to deliver better value based healthcare.

NUHS Media Release
4
Apr
2018

Taking a standard prostate cancer drug with low-fat food, instead of on empty stomach, could boost outcome and lower drug costs by 75% for patients with reduced daily dosage

Others

Prostate cancer patients taking Abiraterone Acetate, a standard drug for prostate cancer, with a low-fat meal instead of on an empty stomach, as prescribed, could decrease their daily dose, boost outcome and lowers cost for the patient.

NCIS Media ReleaseNUHS Media Release
Load More